Cargando…

BuShenKangShuai Tablet Alleviates Hepatic Steatosis via Improving Liver Adiponectin Resistance in ApoE(−/−) Mice

BuShenKangShuai tablet (BSKS) is a Chinese herbal compound, which has been used to treat nonalcoholic fatty liver disease and cardiovascular diseases in clinic for over four decades. This study intends to explore whether BSKS administration can alleviates hepatic steatosis via improving liver adipon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pang, Shu-chao, Wang, Shuo, Chen, Mei-ling, Zhang, Jun-ping, Wang, Yuan-yuan, Jia, Hui-yun, Bi, Li-yuan, Wang, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393934/ https://www.ncbi.nlm.nih.gov/pubmed/30894877 http://dx.doi.org/10.1155/2019/8986038

Ejemplares similares

Bushenkangshuai Tablet Reduces Atherosclerotic Lesion by Improving Blood Lipids Metabolism and Inhibiting Inflammatory Response via TLR4 and NF-κB Signaling Pathway
por: Pang, Shu-chao, et al.
Publicado: (2018)

Shen Shuai II Recipe Attenuates Renal Interstitial Fibrosis by Improving Hypoxia via the IL-1β/c-Myc Pathway
por: Yang, Liuyi, et al.
Publicado: (2021)

ShenShuai II Recipe Attenuates Apoptosis and Renal Fibrosis in Chronic Kidney Disease by Increasing Renal Blood Flow and Improving Oxygen Consumption
por: Wang, Meng, et al.
Publicado: (2018)

ShenKang Injection Attenuates Renal Fibrosis by Inhibiting EMT and Regulating the Wnt/β-Catenin Pathway
por: Wei, Hui-Ting, et al.
Publicado: (2022)

Inhibitory Potential of Shen-Shuai-Ling Formulation on Renal Interstitial Fibrosis via Upregulation of PLZF
por: Song, Na, et al.
Publicado: (2022)

Shen-Kang protects against tacrolimus-induced renal injury
por: Zhang, Long Ye, et al.
Publicado: (2019)

Normalisation of High Bone Remodelling due to Oestrogen Deficiency by Traditional Chinese Formulation Kang Shuai Lao Pian in Ovariectomised Rats
por: Ekeuku, Sophia Ogechi, et al.
Publicado: (2022)

Modulation of the Gut Microbiota by Shen-Yan-Fang-Shuai Formula Improves Obesity Induced by High-Fat Diets
por: Wang, Zhen, et al.
Publicado: (2020)

Shen-Shuai-Ning granule decreased serum concentrations of indoxyl sulphate in uremic patients undergoing peritoneal dialysis
por: Chen, Xujiao, et al.
Publicado: (2018)

Renoprotective Effect of the Shen-Yan-Fang-Shuai Formula by Inhibiting TNF-α/NF-κB Signaling Pathway in Diabetic Rats
por: Lv, Jie, et al.
Publicado: (2017)

Traditional Chinese Medicine Formula Kang Shuai Lao Pian Improves Obesity, Gut Dysbiosis, and Fecal Metabolic Disorders in High-Fat Diet-Fed Mice
por: Gong, Shuqing, et al.
Publicado: (2020)

Protective effects and regulatory mechanisms of Shen-shuai-yi recipe on renal fibrosis in unilateral ureteral obstruction-induced mice
por: Lin, Ping-lan, et al.
Publicado: (2023)

Shen Shuai II Recipe Attenuates Apoptosis in 5/6 Renal Ablation/Infarction Rats by Inhibiting p53 and the Mitochondrial Pathway of Apoptosis
por: Wang, Meng, et al.
Publicado: (2020)

Effect of BuShen JiangZhi Recipe on Atherosclerosis in ApoE(−/-) Mice by Regulating the Expression of Anpep via mmu_circRNA_22187
por: Yan, Li, et al.
Publicado: (2021)

Bu-shen-he-mai-fang (HMF) Decoction Inhibits Atherosclerosis by Improving Antioxidant and Anti-Inflammatory Activities in ApoE-deficient Mice
por: Hao, Qingqing, et al.
Publicado: (2014)

Shen-Shuai-Ling Formulation Attenuates Renal Interstitial Fibrosis in Chronic Kidney Disease by Regulating SHH-Gli1 Signaling Pathway
por: Li, Ying, et al.
Publicado: (2022)

Shen Shuai IIRecipe attenuates renal injury and fibrosis in chronic kidney disease by regulating NLRP3 inflammasome and Sirt1/Smad3 deacetylation pathway
por: Wang, Meng, et al.
Publicado: (2019)

Mechanisms and Molecular Targets of BuShenHuoXue Formula for Osteoarthritis
por: Xiong, Wen, et al.
Publicado: (2022)

Integrating network pharmacology and experimental validation to decipher the mechanism of the Chinese herbal prescription modified Shen-Yan-Fang-Shuai formula in treating diabetic nephropathy
por: Yu, Borui, et al.
Publicado: (2023)

Bu-Shen-Tian-Jing formulas alleviate the mitochondrial damage induced by oxidative stress in ovarian granulosa cells exposed to DEHP through the HDAC3-HSP90AA pathway
por: Zhang, Hui, et al.
Publicado: (2023)

Bu-Shen-Yi-Sui Capsule, an Herbal Medicine Formula, Promotes Remyelination by Modulating the Molecular Signals via Exosomes in Mice with Experimental Autoimmune Encephalomyelitis
por: Zhao, Pei-Yuan, et al.
Publicado: (2020)

Effects of Bu Shen Hua Zhuo formula on the LPS/TLR4 pathway and gut microbiota in rats with letrozole-induced polycystic ovary syndrome
por: Wang, Yang, et al.
Publicado: (2022)

Shen-Kang protects 5/6 nephrectomized rats against renal injury by reducing oxidative stress through the MAPK signaling pathways
por: LIU, MEIYOU, et al.
Publicado: (2015)

Study on the Anti-demyelination Mechanism of Bu-Shen-Yi-Sui Capsule in the Central Nervous System Based on Network Pharmacology and Experimental Verification
por: Zha, Zheng, et al.
Publicado: (2022)

Effects of Bu Shen Yi Sui Capsule on Th17/Treg cytokines in C57BL/6 mice with experimental autoimmune encephalomyelitis
por: Zheng, Qi, et al.
Publicado: (2015)

Bu Shen Zhu Yun Decoction Improves Endometrial Receptivity via VEGFR-2-Mediated Angiogenesis
por: Li, Li, et al.
Publicado: (2019)

Bu Shen Yi Sui Capsule Promotes Myelin Repair by Modulating the Transformation of A1/A2 Reactive Astrocytes In Vivo and In Vitro
por: Zha, Zheng, et al.
Publicado: (2022)

Bu Shen Yi Sui Capsule Alleviates Neuroinflammation and Demyelination by Promoting Microglia toward M2 Polarization, Which Correlates with Changes in miR-124 and miR-155 in Experimental Autoimmune Encephalomyelitis
por: Zha, Zheng, et al.
Publicado: (2021)

Study on the molecular mechanism of BuShenHuoXue capsule in treatment of steroid-induced osteonecrosis of the femoral head
por: Li, Jia-Cheng, et al.
Publicado: (2020)

Bu-Shen-Ning-Xin Decoction ameliorated the osteoporotic phenotype of ovariectomized mice without affecting the serum estrogen concentration or uterus
por: Wang, Ling, et al.
Publicado: (2015)

Bu-Shen-Ning-Xin decoction suppresses osteoclastogenesis by modulating RANKL/OPG imbalance in the CD4(+) T lymphocytes of ovariectomized mice
por: Zhang, Jia-Li, et al.
Publicado: (2018)

QnAs with Le Kang
por: Ahmed, Farooq
Publicado: (2023)

Protective Effects of Bu-Shen-Huo-Xue Formula against 5/6 Nephrectomy-Induced Chronic Renal Failure in Rats
por: Lu, Jian-Rao, et al.
Publicado: (2014)

Chinese Herbal Complex ‘Bu Shen Jie Du Fang' (BSJDF) Modulated Autophagy in an MPP(+)-Induced Cell Model of Parkinson's Disease
por: Liu, Cuifang, et al.
Publicado: (2019)

BuShenYiQi Granule Inhibits Atopic Dermatitis via Improving Central and Skin Hypothalamic -Pituitary -Adrenal Axis Function
por: Kong, Lingwen, et al.
Publicado: (2015)

Effects of Bu Shen Yi sui capsule on NogoA/NgR and its signaling pathways RhoA/ROCK in mice with experimental autoimmune encephalomyelitis
por: Fang, Ling, et al.
Publicado: (2017)

Exploring the Mechanisms of Modified Bu-Shen-Yi-Qi Decoction for COPD-Related Osteoporosis Therapy via Transcriptomics and Network Pharmacology Approach
por: Zhong, Yuanyuan, et al.
Publicado: (2023)

Bu-Fei Yi-Shen Granules Reduce Acute Exacerbations in Patients with GOLD 3–4 COPD: A Randomized Controlled Trial
por: Yu, Xue-Qing, et al.
Publicado: (2023)

Comparative Effectiveness of Di'ao Xin Xue Kang Capsule and Compound Danshen Tablet in Patients With Symptomatic Chronic Stable Angina
por: Yu, Yanan, et al.
Publicado: (2014)

Bu Shen Yi Sui Capsules Promote Remyelination by Regulating MicroRNA-219 and MicroRNA-338 in Exosomes to Promote Oligodendrocyte Precursor Cell Differentiation
por: Ji, Jing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1vrms5l6sqj5jamfsp8eoevjqh